The Florey’s Dr Francesca Alves has been awarded a $735,000 fellowship from the Dementia Australia Research Foundation to develop a potential diagnostic tool and a new targeted treatment for Alzheimer’s disease. In Alzheimer’s, brain cells fail to produce enough energy to stay healthy and function properly and this failure is linked to brain cell damage and death. Dr Alves is developing a…
Read time: 1 min
View more
Florey researchers have found a medication commonly used for blood pressure control holds promise in reducing the risk of sudden unexpected death in epilepsy (SUDEP). The study, which used mouse models, provides strong evidence that protecting the heart during epileptic seizures can reduce the risk of sudden death. There is currently no effective method to predict or prevent SUDEP, the leading…
Read time: 2 mins
View more
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system that affects almost 40,000 Australians and three million people worldwide. Two researchers from The Florey have been awarded combined funding of almost $65,000 from MS Australia to fast track their MS research. The grants will support research on the role genetic mutations in the brain play in…
Read time: 2 mins
View more
Our last public lecture of 2025 was held to recognise the vital work of our mental health researchers with insightful presentations about women's mental health and the intersection between stress and addiction.
Read time: 1 min
View more![[MAY] Neuroscope – Resizing (500 x 500 px)](https://florey.edu.au/wp-content/uploads/2026/03/MAY-Neuroscope-Resizing-500-x-500-px-.png)
Researchers at The Florey have for the first time provided direct evidence to support a long-held hypothesis about where motor neurone disease (MND) starts in the body. For 30+ years research has supported the ‘dying forward’ hypothesis that MND starts and is driven by overactive motor neurons in the brain, rather than neurons in the spine. Cutting-edge technology was used to…
Read time: 2 mins
View more
Your source of neuroscience and mental health insights from The Florey.
ReadA Decade of Impact: A Multi-Level Analysis of WiSPP's Impact on Individuals, Institutions, & the Scientific Community. Wheeler, M. A., Tinning, A. & Russell, S. (2024). A Decade Of Impact: A Multi- Level Analysis Of WiSPP’s Impact On Individuals, Institutions, & The Scientific Community. RMIT University, Melbourne. https://doi.org/10.60836/467h-dj22
ReadMultiple Sclerosis (MS) is an immune-mediated disease of the brain and spinal cord, influenced by multiple risk factors, including genetics. Some rare neurological conditions can mimic MS or occur alongside it, making diagnosis challenging. A group of MS researchers, including experts from the Florey, studied 4,340 people with MS and 2,861 without MS to investigate whether rare changes…
Read time: 3 mins
View more
In honour of her late father Graham, Tania West has established The Graham West Research Grant to support Dr Carlos Gantner’s research at The Florey. Graham was just 70 when has passed away from multiple system atrophy, a rare form of atypical Parkinson’s which progresses rapidly and for which there are no effective therapies available. Dr Gantner’s research investigates the sleep…
Read time: 3 mins
View more
